Literature DB >> 3432041

Determination of atropine in plasma by a direct radioreceptor assay.

K Ensing1, R A De Zeeuw, U Hörnchen, J Schüttler, H Stoeckel.   

Abstract

A highly sensitive radioreceptor assay for the anticholinergic atropine was developed and could be applied directly to plasma samples obtained from mini-pigs without any clean-up. Plasma samples were collected during 6 h after atropine was administered intravenously or endobronchially. The endobronchial plasma concentration-time curves were characterized by a very rapid rise of the concentration but with a subsequent much slower decrease than after intravenous administration. This indicates an initially high as well as prolonged uptake from the lungs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3432041     DOI: 10.1007/BF01956512

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  4 in total

1.  Development and application of a radioreceptor assay for scopolamine.

Authors:  K Ensing; W G in 't Hout; P Halma; H M Klinkers; G J Ensing; R A de Zeeuw
Journal:  Arzneimittelforschung       Date:  1988-01

2.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

3.  Serum lidocaine levels during cardiopulmonary resuscitation after intravenous and endotracheal administration.

Authors:  J L McDonald
Journal:  Crit Care Med       Date:  1985-11       Impact factor: 7.598

4.  [Endobronchial administration of adrenaline in cardiopulmonary resuscitation: pharmacokinetic and dynamic studies in the dog].

Authors:  J Schüttler; U Hörnchen; H Stoeckel; N Hahn
Journal:  Langenbecks Arch Chir       Date:  1987
  4 in total
  1 in total

1.  Application of a radioreceptor assay in a pharmacokinetic study of oxitropium bromide in healthy volunteers after single i.v., oral and inhalation doses.

Authors:  K Ensing; R A de Zeeuw; W G in 't Hout; P J Cornelissen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.